Genky DrugStores to dispose of treasury stock for executive, employee compensation

Genky DrugStores will dispose of 69,000 shares of its common stock as restricted stock compensation on October 10, 2025. The disposal price is 4,870 yen per share, totaling 336,030,000 yen.

This compensation will be allotted to 10 eligible recipients: two company directors will receive 24,000 shares, and eight subsidiary employees will receive 45,000 shares. The company previously filed an Extraordinary Report regarding this treasury stock disposal under the Financial Instruments and Exchange Act.

This initiative follows a board of directors resolution on August 18, 2025, to introduce a restricted stock compensation plan. The plan aims to incentivize sustainable corporate value growth and enhance value sharing with shareholders. The 8th annual general meeting of shareholders on September 11, 2025, approved the scheme, allowing for annual monetary claims up to 200 million yen for restricted stock acquisition and the issuance or disposal of up to 100,000 common shares.

The transfer restriction period for the allotted shares will extend from the disposal date until the recipient resigns or retires from all positions as a director or employee of the company or its subsidiaries. The disposal price of 4,870 yen per share was set based on the closing price of the company's common stock on the Tokyo Stock Exchange Prime Market on September 10, 2025, the business day immediately preceding the board of directors meeting.